In vivo and in vitro characterization of neonatal hyperparathyroidism resulting from a de novo, heterozygous mutation in the Ca2+-sensing receptor gene: normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia.
We characterized the in vivo, cellular and molecular pathophysiology of a case of neonatal hyperparathyroidism (NHPT) resulting from a de novo, heterozygous missense mutation in the gene for the extracellular Ca2+ (Ca2+(o))-sensing receptor (CaR). The female neonate presented with moderately severe...
Main Authors: | Bai, M, Pearce, S, Kifor, O, Trivedi, S, Stauffer, U, Thakker, R, Brown, E, Steinmann, B |
---|---|
Format: | Conference item |
Published: |
1997
|
Similar Items
-
Familial hypocalciuric hypercalcemia as a differential diagnosis of primary hyperparathyroidism with negative images
by: Edwin Antonio Wandurraga-Sánchez, et al.
Published: (2021-12-01) -
Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism.
by: Pearce, S, et al.
Published: (1995) -
Primary Hyperparathyroidism in Homozygous Sickle Cell Patients: A Hemolysis-Mediated Hypocalciuric Hypercalcemia Phenotype?
by: Edmat Akhtar Khan, et al.
Published: (2021-11-01) -
Primary hyperparathyroidism versus familial hypocalciuric hypercalcemia: a challenging diagnostic evaluation in an adolescent female
by: Mustafa Tosur, et al.
Published: (2019-09-01) -
A Patient with Primary Hyperparathyroidism Associated with Familial Hypocalciuric Hypercalcemia Induced by a Novel Germline CaSR Gene Mutation
by: Tomonori Yabuta, et al.
Published: (2009-04-01)